随着10月接近尾声，Oppenheimer看好一些未来一年内有望上涨的股票。10月历来是股市波动较大的月份，今年也不例外。周三，标普500指数和道指均连续第三天收跌。不过，大盘指数和纳指仍有望在本月收涨。目前的涨跌波动伴随着强劲的财报季。截至目前，已 ...

专业制药公司OptiNose (OPTN)于2024年11月9日公布了第三季度财报，承认预期收入有所下降，但重申其旗舰产品XHANCE在慢性鼻窦炎治疗方面的增长潜力。此次电话会议由投资者关系副总裁Jonathan Neely、首席执行官Ramy Mahmoud博士、新任首席财务官Terry Kohler和首席商务官Paul Spence主持，重点讨论了XHANCE的战略计划和市场机遇。 要点摘要 ...

Because of my background in specialty pharmacy work and passion for medicine, I was driven to the field and able to see ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

田纳西州纳什维尔 - 北美知名眼科制药公司Harrow (NASDAQ:HROW)宣布，其干眼症治疗药物VEVYE将从2025年1月1日起被纳入2025年医疗保险D部分处方药计划。这项药物被纳入Express Scripts、Cigna、Kaiser Permanente和CVS Caremark等主要计划赞助商的处方药目录，使VEVYE的覆盖范围扩大到超过2500万医疗保险D部分受益人。

Express Scripts, the largest manager of prescription drug plans for US employers and health plans, and has just announced deals to control the cost of Amgen's Repatha (evolocumab) and Sanofi ...

I'm a 65 year old with 52 years of diabetes type 1. On my HMO plan, I was lead to believe they use Express Scripts. My Endocrinologist writes a prescription on Oct 16th 2024, After my much ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

“Express Scripts and the other pharmacy benefit managers amassed an unprecedented level of power, using it to push opioid pills and conceal unlawful activity," Coleman said Thursday in a statement.